appetite suppressant tirzepatide Microdose Tirzepatide | PeterMD

If side effects from semaglutide are persistent and difficult to manage, discussing a switch to tirzepatide with a provider might be an option, as the body might react differently to the other active ingredient

The mean follow-up on-treatment was 181 days (median 155 days, IQR 71 to 290 days) for tirzepatide initiators and 174 days (median 148 days, IQR 82 to 254 days) for semaglutide initiators

Brand-name versus compounded medication switching The switch looks different depending on whether you are using brand-name products (Ozempic, Wegovy, Mounjaro, Zepbound) or compounded versions

These non-sedating antihistamines are available over the counter

Address sleep apnea if present, which is common in people with obesity and can dramatically improve with weight loss

Maintain hydration and treat GI side effects early